Catecholaminergic polymorphic ventricular tachycardia is a rare, potentially fatal heart rhythm disorder. A new gene therapy candidate from Solid Biosciences is now one step closer to FDA approval. 

The fusion technology integrates pre-procedural MR images of the prostate with intraprocedural ultrasound images in real-time. 

President Donald Trump has crystallized his No. 1 priority for artificial intelligence. Unshockingly, it’s “winning the AI race.” 

In this Radiology Business opinion piece, Linda Wilgus and Kit Crancer explore what the proposed 2026 MPFS means for the specialty and how practices can influence its final form.

Lawmakers on Wednesday introduced the No Surprises Act Enforcement Act, which would increase penalties for failing to comply with payment deadlines under the landmark legislation. 

“The results of our study deserve notice by other states considering similar legislation," says lead author Amy K. Patel, MD, chair of the ACR Advocacy Network. 

In analyzing the impact of the One Big, Beautiful Bill Act, the nonpartisan Congressional Budget Office says Medicaid cuts and new work requirements will cause many Americans to lose their benefits. 

The tricuspid valve has been at the center of several key policy shifts in recent years. In fact, Medicare now covers both T-TEER and TTVR when performed with FDA-approved devices. We spoke to interventional cardiologist Jason H. Rogers, MD, to learn more about how this momentum has impacted patient care.